semaglutide 2.4 mg obesity Long-term weight loss effects of in without diabetes in the SELECT trial Semaglutide (Wegovy) for the Treatment

Bain SC, Hansen BB, Malkin SJP, Nuhoho S, Valentine WJ, Chubb B, Hunt B, Capehorn M

Nausea Vomiting Diarrhea Constipation Decreased appetite Injection-site reactions Gallbladder events (cholelithiasis, cholecystitis) reported in some Phase 2 participants Increased heart rate Possible pancreatitis (per GLP-1 class data not specifically reported in retatrutide trials) Frequently asked questions Is retatrutide FDA-approved

However, it's not listed as a side effect for Ozempic, the diabetes-focused version of semaglutide

The supplement comes in capsule form, which I found easy to work into my morning routine

Treatment approaches, including the use of Semaglutide, are based on the specific needs and characteristics of each patient

SUSTAIN-6 (2016) Injectable semaglutide reduced MACE by 26%, with a striking 39% drop in non-fatal stroke